The global physiotherapy equipment market is projected to reach USD 27.03 billion by 2029 from USD 20.13 billion in 2024, at a CAGR of ...

The ‘Ozempic drug,’ semaglutide, has been found to reduce moderately severe pain caused by knee osteoarthritis and improve ...

Arthritis is a common acute or chronic condition affecting the joints and surrounding tissues. It’s estimated that roughly 18 ...

chiron has developed an advanced organ-on chip technology, which comprises placing of human cells on chips - eg. cells present in the joint - to test the efficacy of drugs. This ground-breaking ...

Some 40 knee arthritis sufferers have undergone the treatment, called genicular arterial embolisation ... causing the cartilage that cushions the ends of the bones in a joint to wear away. The ...

Osteoarthritis of the knee is a common and often painful condition affecting millions worldwide, especially older adults. As ...

During these operations, surgeons traditionally try to put the hip, knee and ankle in a straight line. This study, published in The Bone and Joint Journal, found that to be a bad idea if those parts ...

Do you suffer from knee pain during or after movement? Does knee pain limit your mobility or prevent you from enjoying some activities you previously found joy in? There is mounting evidence that ...

Discover how blood flow restriction (BFR) therapy can enhance knee osteoarthritis recovery by improving pain relief, strength ...

Topline results were announced from a phase 3 clinical trial evaluating subcutaneous semaglutide in obesity and knee osteoarthritis.

But this fairly new diabetes drug seems to have a few more tricks up its sleeve. New research has found that Ozempic (or ...

Only 13 states currently allow Medicaid to cover treatment of obesity using glucagon-like peptide-1 agonist (GLP-1) medications, researchers said.